Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Activity in Alzheimer’s space
View:
Post by GoldenInvestor on Dec 29, 2021 3:09pm

Activity in Alzheimer’s space

News about Biogen being taken out by Samsung.
biogen very depressed.
Comment by Chianchin on Dec 29, 2021 3:40pm
me think GUD's shareholder are far far more depressed. 8 value loosing Years and counting. loosers/investors  keep promoting GUD in the hope that dumb investors will bail them out of their miseries by buying a lot of GUD share. The reality...the only buyer left is............? you got it GUD
Comment by MrMugsy on Dec 29, 2021 7:55pm
Yes - Biogen has been rocked by a few unfortunate situations ... patent issues ... Alzheimer's drug brain swelling and even one associated death ... including pricing changes for their Alzheimer's drug (cut in half).  That AD drug cost could further be cut in the future. So far ... Exelon is my choice over Biogen's drug ... hahaha !
Comment by Chianchin on Dec 30, 2021 8:14am
Again do not be fooled Mugsy/gold is the same person
Comment by MrMugsy on Dec 30, 2021 10:29am
Hmmmm ... looks like Samsung is denying an interest in Biogen.  The stock is now down $20 - almost all it gained on the first rumour.  What to believe ? : )
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities